Lipids

, Volume 42, Issue 1, pp 69–76 | Cite as

Synthetically Lethal Interactions Involving Loss of the Yeast ERG24: The Sterol C-14 Reductase Gene

  • M. Shah Alam Bhuiyan
  • James Eckstein
  • Robert Barbuch
  • Martin Bard
Original Article

Abstract

ERG2 and ERG24 are yeast sterol biosynthetic genes which are targets of morpholine antifungal compounds. ERG2 and ERG24 encode the C-8 sterol isomerase and the C-14 reductase, respectively. ERG2 is regarded as a non-essential gene but the viability of ERG24 depends on genetic background, type of medium, and CaCl2 concentration. We demonstrate that erg2 and erg24 mutants are viable in the deletion consortium background but are lethal when combined in the same haploid strain. The erg2erg24 double mutant can be suppressed by mutations in the sphingolipid gene ELO3 but not ELO2. Suppression occurs on rich medium but not on synthetic complete medium. We also demonstrate that the suppressed elo3erg2erg24 does not have a sterol composition markedly different from that of erg24. Further genetic analysis indicates that erg24 combined with mutations in erg6 or erg28 is synthetically lethal but when combined with mutations in erg3 is weakly viable. These results suggest that novel sterol intermediates probably contribute to the synthetic lethality observed in this investigation.

Abbreviations

CSM

Synthetic complete media

GC

Gas chromatography

PCR

Polymerase chain reaction

YPAD

Yeast extract, peptone, adenine, dextrose

References

  1. 1.
    Lorenz RT, Parks LW (1992) Cloning, sequencing, and disruption of the gene encoding sterol C-14 reductase in Saccharomyces cerevisiae. DNA Cell Biol 11:685–692PubMedCrossRefGoogle Scholar
  2. 2.
    Marcireau C, Guyonnet D, Karst F (1992) Construction and growth properties of a yeast strain defective in sterol 14-reductase. Curr Genet 22:267–272PubMedCrossRefGoogle Scholar
  3. 3.
    Oh CS, Toke DA, Mandala S, Martin CE (1997) ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J Biol Chem 272:17376–17384PubMedCrossRefGoogle Scholar
  4. 4.
    Mercer EI (1993) Inhibitors of sterol biosynthesis and their applications. Prog Lipid Res 32:357–416PubMedCrossRefGoogle Scholar
  5. 5.
    Baloch RI, Mercer EI (1987) Inhibition of Sterol Δ8–Δ7 isomerase and Δ14 reductase by fenpropiomorph, tridemorph, and fenpropidin in cell-free enzyme systems from Saccharomyces cerevisiae. Phytochem 26:663–668CrossRefGoogle Scholar
  6. 6.
    Ladeveze V, Marcireau C, Delourme D, Karst F (1993) General resistance to sterol biosynthesis inhibitors in Saccharomyces cerevisiae. Lipids 28:907–912PubMedCrossRefGoogle Scholar
  7. 7.
    Baudry K, Swain E, Rahier A, Germann M, Batta A, Rondet S, Mandala S, Henry K, Tint GS, Edlind T, Kurtz M, Nickels JT (2001) The effect of the Erg26-1 mutation on the regulation of lipid metabolism in Saccharomyces cerevisiae. J Biol Chem 276:12702–12711PubMedCrossRefGoogle Scholar
  8. 8.
    Crowley JH, Smith SJ, Leak FW, Parks LW (1996) Aerobic isolation of an ERG24 null mutant of Saccharomyces cerevisiae. J Bacteriol 178:2991–2993PubMedGoogle Scholar
  9. 9.
    Crowley JH, Tove S, Parks LW (1998) A calcium-dependent ergosterol mutant of Saccharomyces cerevisiae. Curr Genet 34:93–99PubMedCrossRefGoogle Scholar
  10. 10.
    Lai MH, Bard M, Pierson CA, Alexander JF, Goebl M, Carter GT, Kirsch DR (1994) The identification of a gene family in the Saccharomyces cerevisiae ergosterol biosynthesis pathway. Gene 11:41–49CrossRefGoogle Scholar
  11. 11.
    Silve S, Leplatois P, Josse A, Dupuy PH, Lanau C, Kaghad M, Dhers C, Picard C, Rahier A, Taton M, Le Fur G, Caput D, Ferrara P, Loison G (1996) The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol Cell Biol 16:2719–2727PubMedGoogle Scholar
  12. 12.
    Winzeler EA et al (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 6:901–906CrossRefGoogle Scholar
  13. 13.
    Valachovic M, Bareither BM, Bhuiyan MSA, Eckstein J, Barbuch R, Balderes D, Wilcox L, Sturley SL, Dickson RC, Bard M (2006) Cumulative mutations affecting sterol biosynthesis in the yeast Saccharomyces cerevisiae result in synthetic lethality that is suppressed by alterations in sphingolipid profiles. Genetics 173:1893–1908PubMedCrossRefGoogle Scholar
  14. 14.
    Adams A, Gottschling DE, Kaiser CA, Stearns T (1997) Methods in yeast genetics. Cold Spring Harbor Laboratory Press, New YorkGoogle Scholar
  15. 15.
    Sikorski RS, Hieter P (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19–27PubMedGoogle Scholar
  16. 16.
    Gachotte D, Sen SE, Eckstein J, Barbuch R, Krieger M, Ray BD, Bard M (1999) Characterization of the Saccharomyces cerevisiae ERG27 gene encoding the 3-keto reductase involved in C-4 sterol demethylation. Proc Natl Acad Sci USA 26:12655–12660CrossRefGoogle Scholar
  17. 17.
    Eisenkolb M, Zenzmaier C, Leitner E, Schneiter R (2002) A specific structural requirement for ergosterol in long-chain fatty acid synthesis mutants important for maintaining raft domains in yeast. Mol Biol Cell 13:4414–4428PubMedCrossRefGoogle Scholar

Copyright information

© AOCS 2006

Authors and Affiliations

  • M. Shah Alam Bhuiyan
    • 1
  • James Eckstein
    • 2
  • Robert Barbuch
    • 2
  • Martin Bard
    • 1
  1. 1.Biology DepartmentIndiana University-Purdue University IndianapolisIndianapolisUSA
  2. 2.Department of Drug DispositionEli Lilly and Co., Lilly Corporate CenterIndianapolisUSA

Personalised recommendations